Liver Cancer and Metastases

Read full text Summarise with VIRAT
Authors: Muhammad Usman, Zain ul Abedin, Zohaib Masih and; Asifa Kabir
Cited by: 0
References: 77

Summary

No summary yet. VIRAT can read this paper and write a plain-language summary of its aim, methods, key findings and limitations.

Summarise with VIRAT Free to try with your Science Catalogs account.

Abstract

Hepatocellular carcinoma (HCC), occasionally shortened to primary liver cancer (LC), is now the third leading cause of deaths due to cancer worldwide. It is ranked fifth among cancers in men and seventh among cancers in women. It is a malignant tumor in liver tissue. The most common causes of LC are infection with the Hepatitis B or C virus, alcoholic and nonalcoholic liver disease (ALD, NAFLD), nonalcoholic steatohepatitis (NASH), cigarette smoking, and obesity. Morphological as well as genetic characteristics play a multistage, branching role in the occurrence and progression of carcinoma in liver cells. The liver metastasis process has been divided into four main stages: microvascular, preangiogenic, angiogenic, and growth phases. Overall, more than 90% of solid tumor-related deaths are known to be caused by metastatic illness. Drug resistance becomes apparent like sorafenib have potential side effects and drug inefficiency when used for a long time and the treatment is advantageous to fewer than a third of the patients. A variety of natural substances that both stimulate and repress systems linked to cancer prevention. These metabolites trigger protective, antiinflammatory, anticarcinogenic, and antiproliferative processes that may provide alternative treatments to contemporary cancer therapy strategies. Nanotechnology can help minimally effective medications target and destroy cancer cells more effectively. Because LC has a poor prognosis, researchers and doctors are looking for new ways to treat the disease in order to increase patient survival. Integrating therapeutic drugs and modifying how they are delivered and consumed creates novel perspectives in enhancing cancer survival rates.

Fields of Study & Subjects

Hepatocellular Carcinoma Treatment and Prognosis Liver physiology and pathology Colorectal Cancer Treatments and Studies

Publication details

Journal / source
IntechOpen eBooks
Publication date
6 March 2026
Language
EN
Document type
Book chapter